FibroBiologics (Direct Listing) FBLG 深 沪
等待开盘 12-18 09:30:00 美东时间
0.2758
+0.035
+14.53%
华盛通- 最 高0.286
- 今 开0.246
- 成交量 226.16万股
- 最 低 0.2405
- 昨 收 0.2408
- 总市值 1419.16万
- 52周最高 2.3859
- 市盈率 静 --
- 换手率 4.40%
- 52周最低 0.2353
- 委 比 22.70%
- 总股本 5145.61万
- 历史最高 55.00
- 量 比 0.74
- 振 幅 18.90%
- 历史最低 0.2353
- 每 手 1
- 风险率 0.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Lexaria Bioscience (NASDAQ:LEXX) stock increased by 6.5% to $0.89 durin...
12-17 05:05
FibroBiologics announces $1.7M registered direct offering
FibroBiologics (NASDAQ:FBLG) announced on Monday that it has entered into an agreement for the issuance and sale of an aggregate of 5.23M shares of its common stock at an offering price of $0.33 per s...
12-15 21:56
FibroBiologics Files New USPTO Patent For Fibroblast-Derived Spheroid Platform Aimed At Cartilage And Disc Repair
FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for
12-10 21:35
FibroBiologics Announces That It Has Fully Repaid All Outstanding Amounts Under Its Convertible Promissory Notes Issued To Yorkville
FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for
11-26 21:35
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
11-21 15:50
D. Boral Capital Maintains Buy on FibroBiologics, Maintains $15 Price Target
D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $15 price target.
11-20 21:08
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock rose 10.2% to $2.8 during Wedn...
11-20 05:07
FibroBiologics shares are trading lower after the company priced a $4 million registered direct offering.
FibroBiologics shares are trading lower after the company priced a $4 million r...
11-19 21:38
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $5
HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and lowers the price target from $10 to $5.
11-05 19:29
